150 related articles for article (PubMed ID: 8684768)
1. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.
Wolf JK; Levenback C; Malpica A; Morris M; Burke T; Mitchell MF
Obstet Gynecol; 1996 Jul; 88(1):82-6. PubMed ID: 8684768
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
6. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
7. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
10. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
13. Cervical adenocarcinoma in situ.
Hopkins MP; Roberts JA; Schmidt RW
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):842-4. PubMed ID: 3285263
[TBL] [Abstract][Full Text] [Related]
14. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
Salani R; Puri I; Bristow RE
Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
[TBL] [Abstract][Full Text] [Related]
16. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
Im DD; Duska LR; Rosenshein NB
Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
[TBL] [Abstract][Full Text] [Related]
17. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
19. Residual disease after cone biopsy: completeness of excision and follow-up cytology as predictive factors.
Buxton EJ; Luesley DM; Wade-Evans T; Jordan JA
Obstet Gynecol; 1987 Oct; 70(4):529-32. PubMed ID: 3627622
[TBL] [Abstract][Full Text] [Related]
20. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
Dedecker F; Graesslin O; Bonneau S; Quéreux C
Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
